Track SDGR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Schrodinger Inc
1540 Broadway, New York, NY, United States, 10036
IPO
2020
Employees
850
Industry
Health Information Services
Sector
Healthcare
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q2 20262-2
0
Q1 202612-12
0
Q4 20251-1
0
3-quarter cumulative
15 sells0 buys
Analyst Ratings
2 analysts covering
Hold100%recommend hold
Buy
0
Hold
2
Sell
0